Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover.
PRNewsWire11/6/2026Neutral
ZBH
Zimmer Biomet Holdings IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$20.38B
P/E Ratio
26.98
EPS
$3.96
Beta
0.47
52W High
$112.55
52W Low
$78.70
50-Day MA
$95.00
200-Day MA
$91.94
Dividend Yield
0.90%
Profit Margin
8.95%
Forward P/E
12.18
PEG Ratio
0.69
About Zimmer Biomet Holdings Inc
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Fundamentals
| Revenue (TTM) | $8.57B |
| Gross Profit (TTM) | $5.94B |
| EBITDA | $2.54B |
| Operating Margin | 17.30% |
| Return on Equity | 6.03% |
| Return on Assets | 3.81% |
| Revenue/Share (TTM) | $44.24 |
| Book Value | $64.95 |
| Price-to-Book | 1.47 |
| Price-to-Sales (TTM) | 2.38 |
| EV/Revenue | 3.28 |
| EV/EBITDA | 12.33 |
| Quarterly Earnings Growth (YoY) | -13.80% |
| Quarterly Revenue Growth (YoY) | 3.10% |
| Shares Outstanding | $190.74M |
| Float | $188.65M |
| % Insiders | 0.16% |
| % Institutions | 112.12% |
Historical Volatility
HV 10-Day
72.73%
HV 20-Day
53.79%
HV 30-Day
46.82%
HV 60-Day
38.74%
HV Rank
88.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($106.90 target)
2
Strong Buy6
Buy19
HoldLatest News
Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research11/5/2026Positive
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript
Seeking Alpha11/4/2026Neutral
Zimmer Biomet Stock Up on Q3 Earnings & Revenue Beat, '26 View Up
ZBH beats Q3 earnings and revenue estimates, lifting its 2026 outlook as strong Hips and S.E.T. sales offset weakness in Knees amid margin pressure.
Zacks Investment Research11/4/2026Positive
Zimmer (ZBH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research11/4/2026Positive
Zimmer Biomet (ZBH) Q3 Earnings and Revenues Beat Estimates
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.9 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $1.9 per share a year ago.
Zacks Investment Research11/4/2026Positive
Zimmer Biomet Announces Third Quarter 2026 Financial Results
Third quarter net sales of $2.063 billion increased 3.1% on a reported basis and 3.7% on a constant currency1 basis Third quarter diluted earnings per share were $1.00, a decrease of 13.8%; adjusted1 diluted earnings per share were $1.90, consistent with the prior year period Company updates full-year 2026 financial guidance WARSAW, Ind., Nov. 4, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2026.
PRNewsWire11/4/2026Neutral
Zimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards?
ZBH heads into Q3 earnings with growth expected in Hips, S.E.T. and Technology & Data, while Knee sales face ongoing pressure.
Zacks Investment Research10/29/2026Neutral
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research10/29/2026Positive
Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026
Featured symposium will reveal a new vision for intelligent systems that support surgeon judgment, reduce procedural burden and connect the episode of care WARSAW, Ind., Oct. 29, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its plans to host a featured symposium and booth discussions to reveal a new vision for intelligent orthopedic surgery at the 2026 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS), taking place November 5–8 in the Dallas area.
PRNewsWire10/29/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ZBH and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 11/7/2026